Clinicopathological significance of combined analysis of cytokeratin19 expression and preoperative serum CYFRA21-1 levels in human lung squamous cell carcinoma.

Osaka city medical journal

Volumn 59, Issue 1, 2013, Pages 35-44

  Hanada, Shoji ^a   Nishiyama, Noritoshi ^b   Mizuguchi, Shinjiro ^b   Yamano, Shotaro ^b   Kakehashi, Anna ^b   Wei, Min ^b   Inoue, Hidetoshi ^b   Komatsu, Hiroaki ^b   Chung, Kyukwang ^b   Suehiro, Shigefumi ^b   Wanibuchi, Hideki ^b  

^a OSAKA CITY UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ANTIGEN CYFRA21.1; CYTOKERATIN 19; TUMOR ANTIGEN; TUMOR MARKER;

ADULT; AGED; ARTICLE; BLOOD; CHEMISTRY; CHI SQUARE DISTRIBUTION; FEMALE; HUMAN; IMMUNOHISTOCHEMISTRY; KAPLAN MEIER METHOD; LIQUID CHROMATOGRAPHY; LUNG TUMOR; MALE; METHODOLOGY; MIDDLE AGED; MORTALITY; MULTIVARIATE ANALYSIS; PATHOLOGY; PREDICTIVE VALUE; PROGNOSIS; PROPORTIONAL HAZARDS MODEL; PROTEOMICS; RISK FACTOR; SQUAMOUS CELL CARCINOMA; TANDEM MASS SPECTROMETRY; TIME; VERY ELDERLY;

ADULT; AGED; AGED, 80 AND OVER; ANTIGENS, NEOPLASM; CARCINOMA, SQUAMOUS CELL; CHI-SQUARE DISTRIBUTION; CHROMATOGRAPHY, LIQUID; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; KAPLAN-MEIER ESTIMATE; KERATIN-19; LUNG NEOPLASMS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; PREDICTIVE VALUE OF TESTS; PROGNOSIS; PROPORTIONAL HAZARDS MODELS; PROTEOMICS; RISK FACTORS; TANDEM MASS SPECTROMETRY; TIME FACTORS; TUMOR MARKERS, BIOLOGICAL;

EID: 84882342355     PISSN: 00306096     EISSN: None     Source Type: None    
DOI: None     Document Type: Article

References (0)